These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
Cosimo I de Medici
Printmaker:
Vorsterman, Lucas Emil
Painter:
Rubens, Peter Paul
(After)
History note: From the collection of A. Morrison (1821-1897) [Lugt 151]; John Charrington [Lugt 572] bought at his sale (Sotheby's) 22nd November 1927, lot 252 (with P.9105-R, P.9229-R, P.9230-R, P.9231-R, P.9233-R and one other)
Method of acquisition: Given (1933) by Charrington, John
Printed on one sheet with Giacomuzzo Attendolo Sforza (P.9233-R
Accession number: P.9232-R
Primary reference Number: 149840
Lugt: 572
Lugt: 151
Hollstein (Dutch/Flemish): 186
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "Cosimo I de Medici" Web page available at: https://collection.beta.fitz.ms/id/object/149840 Accessed: 2024-11-24 21:41:39
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://collection.beta.fitz.ms/id/object/149840
|title=Cosimo I de Medici
|author=The Fitzwilliam Museum|accessdate=2024-11-24 21:41:39|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://collection.beta.fitz.ms/api/v1/objects/object-149840
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp19/P_9232_R.jpg"
alt="Cosimo I de Medici"
class="img-fluid" />
<figcaption class="figure-caption text-info">Cosimo I de Medici</figcaption>
</figure>
</div>
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
